UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2008, ISBN 3527318224, xx, 418
Book
2015, Biomedical engineering collection, ISBN 1606506676, xxviii, 295
Book
1999, Practical approach series, ISBN 0199637768, Volume 205, xx, 210
Book
1995, 1, ISBN 0849347785, 305
Book
Nucleic acid therapeutics, ISSN 2159-3337, 12/2014, Volume 24, Issue 6, pp. 374 - 387
Reviews | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Rabbits | History, 20th Century | Humans | Oligonucleotides, Antisense - chemistry | Oligonucleotides, Antisense - metabolism | Phosphorothioate Oligonucleotides - history | Transcription Factors - metabolism | Animals | Oligonucleotides, Antisense - therapeutic use | Protein Binding | Phosphorothioate Oligonucleotides - metabolism | Mice | Phosphorothioate Oligonucleotides - chemistry | Phosphorothioate Oligonucleotides - therapeutic use | Oligonucleotides, Antisense - history | Phosphates | Clinical trials | Enzymes | Biochemistry | Pharmacology | Sulfur | Index Medicus
Journal Article
2008, ISBN 9789812790453, xi, 118
Book
European journal of pharmaceutics and biopharmaceutics, ISSN 0939-6411, 09/2013, Volume 85, Issue 1, pp. 5 - 11
Endocytosis | Oligonucleotide | siRNA | Delivery | Cell-penetrating peptide | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Oligonucleotides - therapeutic use | Humans | Oligonucleotides - adverse effects | Endosomes - metabolism | Oligonucleotides - pharmacokinetics | Tissue Distribution | Cell-Penetrating Peptides - therapeutic use | Cell-Penetrating Peptides - adverse effects | Oligonucleotides, Antisense - therapeutic use | Endosomes - drug effects | Chemistry, Pharmaceutical - trends | RNA, Small Interfering - pharmacokinetics | Endocytosis - drug effects | Oligonucleotides, Antisense - pharmacokinetics | Gene Silencing | RNA, Small Interfering - adverse effects | Oligonucleotides, Antisense - adverse effects | Genetic Therapy - trends | Animals | RNA, Small Interfering - therapeutic use | Oligonucleotides, Antisense - administration & dosage | Drug Delivery Systems - trends | Oligonucleotides - administration & dosage | RNA, Small Interfering - administration & dosage | Drug Delivery Systems - adverse effects | Genetic Therapy - adverse effects | Peptides | Index Medicus
Journal Article
Annual review of pharmacology and toxicology, ISSN 0362-1642, 02/2010, Volume 50, Issue 1, pp. 259 - 293
Antisense oligonucleotides | RNase H | RNA interference | RNA | RNA splicing | Biological and medical sciences | Miscellaneous | Medical sciences | General pharmacology | Pharmacology. Drug treatments | RNA - physiology | Animals | Oligonucleotides, Antisense - pharmacology | Humans | Oligonucleotides, Antisense - pharmacokinetics | Oligonucleotides, Antisense - therapeutic use | Oligonucleotides, Antisense - chemistry | Physiological aspects | Research | Ribonuclease | Oligonucleotides | Index Medicus
Journal Article
2007, ISBN 9780309112987, xxii, 275
Book
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10002, pp. 1472 - 1483
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Apolipoproteins A - administration & dosage | Apolipoproteins A - genetics | Oligonucleotides, Antisense - pharmacology | Double-Blind Method | Humans | Middle Aged | Oligonucleotides, Antisense - pharmacokinetics | Apoprotein(a) - antagonists & inhibitors | Treatment Outcome | Healthy Volunteers | RNA, Messenger - metabolism | Oligonucleotides - pharmacokinetics | Young Adult | Oligonucleotides - pharmacology | Adolescent | Protein Binding | Adult | Oligonucleotides, Antisense - administration & dosage | Aged | Oligonucleotides - administration & dosage | Apolipoproteins | Lipoprotein A | Drugs | Studies | Plasma | Atherosclerosis | Cardiovascular disease | Drug therapy | Low density lipoprotein | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Nucleic acids research, ISSN 0305-1048, 6/2011, Volume 39, Issue 11, pp. 4795 - 4807
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Phosphorothioate Oligonucleotides - analysis | Oligonucleotides, Antisense - chemistry | Oligonucleotides, Antisense - metabolism | Male | Mice, Transgenic | Hepatocytes - metabolism | Endocytosis | Animals | Cell Line, Tumor | Oligonucleotides, Antisense - analysis | Phosphorothioate Oligonucleotides - metabolism | Mice | Mice, Inbred BALB C | Phosphorothioate Oligonucleotides - chemistry | Kinetics | Index Medicus | Cell culture | Animal models | Clathrin | Carcinoma | Caveolin | Chloroquine | Liver | Brefeldin A | Lysosomes | Antisense oligonucleotides | mRNA | siRNA | Tumor cell lines | adaptor proteins | Hepatocytes | phosphorothioate | Molecular Biology
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 3, pp. 222 - 232
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Oligonucleotides - therapeutic use | Humans | Middle Aged | Male | Angiopoietins - antagonists & inhibitors | Dyslipidemias - blood | Angiopoietin-like Proteins | Oligonucleotides - pharmacology | Lipids - blood | Oligonucleotides, Antisense - therapeutic use | RNA, Messenger - antagonists & inhibitors | Adult | Female | Disease Models, Animal | Dyslipidemias - drug therapy | Atherosclerosis - drug therapy | Oligonucleotides, Antisense - pharmacology | Double-Blind Method | Coronary Artery Disease - metabolism | Mice, Inbred Strains | Atherosclerosis - metabolism | Animals | Coronary Artery Disease - genetics | Lipid Metabolism - drug effects | Aged | Mice | Angiopoietins - genetics | Atherosclerosis - prevention & control | Care and treatment | Research | Blood lipids | RNA | Oligonucleotides | Atherosclerosis | Plasma | Lipoproteins (low density) | Angiopoietin | Lipids | Antisense RNA | Antisense oligonucleotides | Triglycerides | mRNA | Gene expression | Apolipoproteins | Low density lipoprotein | Cholesterol | Apolipoprotein B | Lipoproteins | Apolipoprotein C-III | Arteriosclerosis |